Intraocular lenses (IOLs) are micro lenses that are placed inside your eye to correct cataracts, nearsightedness, farsightedness or presbyopia. There are two types of IOLs: anterior chamber lenses, which are placed in the anterior chamber of the eye between the iris and the cornea, and posterior chamber lenses, which are placed in the posterior chamber behind the iris and rest against the capsular bag.

You can swim and participate in virtually any other activity with the Verisyse™ Phakic IOL because unlike contact lenses, the Verisyse™ Phakic IOL is implanted in the eye, in front of the crystalline lens. Therefore, it is not affected by external elements such as water.

Once the Verisyse™ Phakic IOL is placed inside your eye, it is virtually undetectable; however, you and others may be able to see the lens in your eye if you look very closely. Because the Verisyse™ Phakic IOL is placed inside your eye, you will not be able to feel it.

The phakic IOL is a micro lens placed behind your cornea. It is made out of PMMA, the same material used safely for the past 50 years in cataract surgery. “Phakic” means that your natural crystalline lens is left in the eye. Your natural lens helps your eye adjust between seeing objects that are near or far.

Phakic IOL is specifically designed to provide precise vision correction for very nearsighted people who are not candidates for Custom LASIK. The corneal shape is not altered. A specially designed IOL is placed inside the eye to refocus light rays onto the retinal surface similar to glasses or contacts. LASIK is an excellent procedure for people with lower levels of nearsightedness. The corneal curvature is altered to correct the nearsightedness and/or astigmatism.

For patients 45 years or younger, you will be able to see at a distance and up close after surgery because your natural crystalline lens is left in place allowing natural adjustments to focus on near and distant objects. After age 45, you can expect to need reading glasses for close work just like other people who see well at distance at this age.

A lens implant (intraocular lens or IOL) is a man-made, clear plastic lens approximately 6 millimeters in diameter which is placed inside the eye at the time the cataract is removed. It replaces the natural lens and remains permanently within the eye. The lens has small spring-like arms called haptics that prevent the lens from moving out of place.

Yes. The Verisyse™ Phakic IOL is made from polymethyl methacrylate (PMMA) — an extremely well proven biocompatible material that has been widely used in and on eyes for over 50 years.

The phakic intraocular lens, which has recently been FDA approved is a non-laser treatment. In the intraocular lens treatment we make an incision in the side of the cornea, place an artificial lens between the iris and the eye's natural lens, then close the incision. The treatment is a potential alternative for patients whose refractive error is outside that treated by LASIK-higher nearsightedness and farsightedness.

The Visian ICL is one of several Phakic lenses. A Phakic lens means that the natural lens of the eye is not removed, but remains in place behind the new artificial lens. In contrast, during cataract surgery, the natural lens, which has become cloudy and damaged, is removed before a new implant is inserted.

The procedure involves placing the Verisyse™ Phakic IOL behind your cornea and on top of your iris. This gives your eye another focusing lens that provides high-quality, high-definition vision like a normal eye. Although the Verisyse™ Phakic IOL is intended to be permanent, the procedure is reversible if desired. The word “phakic” means that your natural crystalline lens is left in the eye.

Wireless Consortium FAQ Below is a periodically updated list of frequently asked questions about the Wireless LAN (WLAN) Consortium. For additional information, see the shortcut links on the WLAN home page, or forward any additional inquiries to wclab@iol.unh.edu.

The University of New Hampshire InterOperability Laboratory (UNH-IOL) tests networking and data communications products. The university established the laboratory in 1988 with the dual mission of providing a neutral environment to foster multi-vendor interoperability and conformance to data communications networking standards while educating students for future employment in the industry.

IOL Technology is published by Independent Online (IOL), a subsidiary of Independent Newspapers (SA), which is part of the global Independent News and Media Group. Independent Newspapers (SA) publishes 15 national and regional newspapers in South Africa.

The lens is important for focusing. When it's removed, it usually needs to be replaced. 90 percent of times IOLs help achieve 6/12 vision or better. IOL is a clear, polymer (Silicone or Acrylic) lens that is placed in the eye during cataract surgery. It does not need any after-care. With IOL one does not need to wear glasses for most of their work and moving about. Moreover, the area of clear vision is much wider. However, for fine near of distant work one may still need low powered glasses.

Once implanted, the lens will not fall out. The lens is extremely secure because it is carefully attached to your iris. There have been rare occurrences of the lens becoming detached from the iris. If this occurs, you would notice a decrease in vision. The lens could then be easily reattached to the iris by your surgeon.

There is a very slightly increased risk of surgical complications, such as displacement of the IOL, but most people feel that the benefits far outweigh the risk. Today, almost all patients having cataract surgery safely choose an IOL as part of the procedure.

More than 100 graduate and undergraduate student-employees from the University of New Hampshire work with full-time UNH-IOL staff, gaining hands-on experience with developing technologies and products from hundreds of major companies.

The iSCSI Consortium is a world class test house for iSCSI products. The consortium brings together members and industry to foster interoperability among iSCSI products and increase the market feasibility of iSCSI technology. Like other UNH-IOL Consortiums, the iSCSI Consortium is fully funded by our member companies.